Published July 18, 2022 | Version v1

Peculiarities of neoplasms , appeared after total body irradiation and homeostasis parameters in rats.

  • 1. Department of Means & Methods of Adsorptive therapy, R. E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, National Academy of Sciences of Ukraine, 03022 Kyiv, Ukraine
  • 2. Department of Cytology, Histology and Reproductive Medicine, Institute of Biology and Medicine, Taras Shevchenko National University of Kyiv, 01033 Kyiv, Ukraine
  • 3. Department of Monitoring of Tumor Process and Therapy Design, R. E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, National Academy of Sciences of Ukraine, 03022 Kyiv, Ukraine
  • 4. Laboratory of Biochemistry, National Cancer Institute of Ukraine,03022 Kyiv, Ukraine

Description

Background: Tissue damage and disruption of metabolic processes as a result of total body irradiation (TBI) could lead to tumorigenesis.
Methods: 25 from 32 rats were total body X- irradiated  with sublethal dosage per rat - 6 Gy. On month 12±1 ,19 of  irradiated animals had visually detectable tumors. In this period all rats were sacrificed. The alkaline phosphatase (ALP) ; alanine aminotransferase (ALT), aspartate aminotransferase (AST),  amylase , lactate dehydrogenase (LDH) ; Ca 2+ ; creatinine ; glucose ; phosphorus ; urea  ; uric acid , total protein, pO2, pCO2, pH, blood cell level  were measured in blood. Tumors were isolated, measured and histologically examinated. Accordingly the ratio ( C1) of tumor weight   to lactate level in blood   in tumor bearing rats, the animals  were  divided on 3 conditional groupings K1-K3 with C1<0.5; C1 >0.5<1.5; C1> 1.5.
Results: About a year after TBI (12±1 months) 76% of female rats had visually detected tumors, which were histologically classified as benign fibro adenomas. Metabolic disorders and hematological changes observed during this period indicate disturbances in the homeostasis system. The blood lactate level in all tumor-bearing animals was statistically higher than in control (healthy) rats; a typical phenomenon for neoplasm growth. In the majority of animals with neoplasms (63%), the tumor weight and the levels of lactate and lactate dehydrogenase (LDH) in the blood were in direct relation (coefficient = tumor weight / lactate level >0.5<1.5) and histological analysis revealed the signs of biphasic hyperplasia of glandular lobes and connective tissue stroma, associated with secretory and proliferative activities in tumor.  In the conditional grouping of animals with relatively high values of coefficient (≥1.5), neoplasms were represented by fibrous and glandular tissues presenting a predominant stromal fibrous component, associated with the prevalence of high proliferation in tumor. While in the rat conditional grouping (20% of animals) with a relatively low coefficient (< 0.5) an epithelial structure with homogeneous basophilic content predominated in the glandular lumens, suggesting the domination of high secretory activity in tumor.
Conclusions:  Total body irradiation promoted the alterations of hematological and biochemical parameters of homeostasis in rats and provoked the appearance of benign tumors one year after. Coefficient C – the  ratio of tumor mass  to lactate or LDH value in blood seems to be an informative indicator of the histological peculiarities of tumor, suggesting  the prevalence of proliferative  or secretory activity , or the balance between proliferative and secretory activities of tumor cells.  
 

Files

1-1x20.tiff

Files (752.7 MB)

Name Size
md5:b28c3b35a2c85ab113928627df067eda
9.5 MB Preview Download
md5:715c533027c19dcb6a392bf613db2b6d
10.0 MB Preview Download
md5:ed69d1bc7ffc41bab9cc47a9d259eb9d
7.8 MB Preview Download
md5:6e80886d6d906ca5c42ec0b299733c5d
15.1 MB Preview Download
md5:c156d2a631d3ecbc4f7c726d485d4e4e
15.1 MB Preview Download
md5:8af4fb821a4715fb8c1179ff64e7362a
15.1 MB Preview Download
md5:e8743b6c1cfa2c6e36c5683e961f79ba
15.1 MB Preview Download
md5:0d2d9a891d62485d0fb1b88aafc1743e
15.1 MB Preview Download
md5:3a3905c45ac55940f13fc14e48665337
15.1 MB Preview Download
md5:aca4d5cd44ef2e32b5ab202d0574a18d
15.1 MB Preview Download
md5:2cb735309e5e08cc5e28c9cbcda60734
15.1 MB Preview Download
md5:e60625e7ae76a4d1dc603342cd208238
15.1 MB Preview Download
md5:c1bf4977fbea9346dacaedd4efd7d1b8
15.1 MB Preview Download
md5:443ed83b7906aa7506c3de1f19a9237f
15.1 MB Preview Download
md5:d0f5f46ccbb244cb198d1bcd4c7d1c4b
15.1 MB Preview Download
md5:c73a5d333fa29521205f03195ac21dae
15.1 MB Preview Download
md5:426a2942b7634c775dde82db758fa6b3
15.1 MB Preview Download
md5:5ea391734098101ec36ad283cd2facbf
15.1 MB Preview Download
md5:1de4fd19ef1499ec4118a3bc615fc670
15.1 MB Preview Download
md5:9468f1132db5e85c59e3c0e75517b62c
15.1 MB Preview Download
md5:d255f4e8f6aeb213152e1227a5564d7a
15.1 MB Preview Download
md5:930a543185af1e52ccf8683b93c13ba6
15.1 MB Preview Download
md5:ce0ae49cd26bb913c7453e3d7c45feba
15.1 MB Preview Download
md5:b80b52361a686308d601fb1b16d03607
15.1 MB Preview Download
md5:89b1bffd7947943d8d5065d923287ba8
9.6 MB Preview Download
md5:ee567a878fb37176e2589fefe7152e92
10.4 MB Preview Download
md5:4010070446d42dceeb052333b4dc7f38
7.8 MB Preview Download
md5:303e1fa434b441875d377b007c990aa4
9.5 MB Preview Download
md5:7322fecd855972da9e115f19944cf59f
10.2 MB Preview Download
md5:dd01f8ff960b3f70a1d2ca651361dee5
9.1 MB Preview Download
md5:ab76e9d57d4a1918d7fa92941fe379fe
9.6 MB Preview Download
md5:e4eff02fea465a8844fc474eb44e6b26
7.8 MB Preview Download
md5:ee0fc25b8c3b61b08e1d2747cd654554
6.5 MB Preview Download
md5:338674cd8e6827738569e595c7fd7d47
11.9 MB Preview Download
md5:b282a2e9c68686332b5d8813e242f7c3
12.1 MB Preview Download
md5:de70a96920433621999d0425fa793a78
9.4 MB Preview Download
md5:24de2f309b6a248c75d1764b82f87a79
11.1 MB Preview Download
md5:e166d109f33ab5d5d585151c843a97a4
11.4 MB Preview Download
md5:1a4249cfc65fb7eaf0bbdd73c9f969a9
8.8 MB Preview Download
md5:7cc033648bfff430d77f4fef63422ba3
9.5 MB Preview Download
md5:67d8dc85db8cad0067397fb419b00574
9.3 MB Preview Download
md5:d63af55411f33243d2c4b8be912ae3b2
15.1 MB Preview Download
md5:ae19f7c7179d46bd5d5803cc99179107
15.1 MB Preview Download
md5:fc307241924a30b5ed22386f1bceeb3d
15.1 MB Preview Download
md5:7e760fbbb8a25327b0e366ac75acb531
15.1 MB Preview Download
md5:ae3848d129f660fa084422209b770537
15.1 MB Preview Download
md5:12e6a67877a01193ca4070978131b9a6
15.1 MB Preview Download
md5:22d9c71b3ad2a7cc55ee9bef4633e122
15.1 MB Preview Download
md5:d10f2d2836f507bf3014419c1fa729e4
15.1 MB Preview Download
md5:0af8dbdbeec9aa473048df4e4a86d32e
15.1 MB Preview Download
md5:63846b1abf98103bf3f1b604b0b874af
15.1 MB Preview Download
md5:680fe8796b394de60eec335814523247
15.1 MB Preview Download
md5:8a2c9a4130d927786c28879936a74a5d
15.1 MB Preview Download
md5:98ab5c5396f3eebfa05b4df51bf3ce43
15.1 MB Preview Download
md5:9f001bd0ad071892b9288f43683941ad
15.1 MB Preview Download
md5:95436378a30972882cf94c836d96fb7f
15.1 MB Preview Download
md5:0964e214d90b81e9c3a7874632475804
15.1 MB Preview Download
md5:947205839b06135b04513f6903ac97ef
2.2 MB Download
md5:3c165d137f84673a841ec7d7ab685a2f
21.6 kB Download

Additional details

Funding

European Commission
NanoMed - Nanoporous and Nanostructured Materials for Medical Applications 734641